BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20529086)

  • 1. Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.
    Kaas A; Pfleger C; Hansen L; Buschard K; Schloot NC; Roep BO; Mortensen HB;
    Clin Exp Immunol; 2010 Sep; 161(3):444-52. PubMed ID: 20529086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.
    Pfleger C; Mortensen HB; Hansen L; Herder C; Roep BO; Hoey H; Aanstoot HJ; Kocova M; Schloot NC;
    Diabetes; 2008 Apr; 57(4):929-37. PubMed ID: 18299313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
    Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
    Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients.
    Gabbay MA; Sato MN; Duarte AJ; Dib SA
    Clin Exp Immunol; 2012 Apr; 168(1):60-7. PubMed ID: 22385239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
    Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating anti-glutamic acid decarboxylase-65 antibody titers are positively associated with the capacity of insulin secretion in acute-onset type 1 diabetes with short duration in a Japanese population.
    Yamamura S; Fukui T; Mori Y; Hayashi T; Yamamoto T; Ohara M; Fukase A; Sasamori H; Kobayashi T; Hirano T
    J Diabetes Investig; 2019 Nov; 10(6):1480-1489. PubMed ID: 30919585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
    Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
    Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
    Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
    Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.
    Redondo MJ; Rodriguez LM; Escalante M; Smith EO; Balasubramanyam A; Haymond MW
    Pediatr Diabetes; 2013 Aug; 14(5):333-40. PubMed ID: 23458188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal dynamics of serum let-7g expression mirror the decline of residual beta-cell function in longitudinal observation of children with type 1 diabetes.
    Małachowska B; Wyka K; Nowicka Z; Bartłomiejczyk MA; Młynarski W; Fendler W
    Pediatr Diabetes; 2018 Dec; 19(8):1407-1415. PubMed ID: 30259606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
    Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
    Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.
    Decochez K; Tits J; Coolens JL; Van Gaal L; Krzentowski G; Winnock F; Anckaert E; Weets I; Pipeleers DG; Gorus FK
    Diabetes Care; 2000 Jun; 23(6):838-44. PubMed ID: 10841006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes.
    Harms RZ; Ostlund KR; Cabrera MS; Edwards E; Fisher M; Sarvetnick N
    Front Immunol; 2020; 11():1922. PubMed ID: 33042112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes.
    Steck AK; Liu X; Krischer JP; Haller MJ; Veijola R; Lundgren M; Ahmed S; Akolkar B; Toppari J; Hagopian WA; Rewers MJ; Elding Larsson H
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1380-e1388. PubMed ID: 33035311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes.
    Kaas A; Pfleger C; Kharagjitsingh AV; Schloot NC; Hansen L; Buschard K; Koeleman BP; Roep BO; Mortensen HB; Alizadeh BZ;
    Diabet Med; 2012 Jun; 29(6):734-41. PubMed ID: 22150609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher risk of severe hypoglycemia in children and adolescents with a rapid loss of C-peptide during the first 6 years after type 1 diabetes diagnosis.
    Grönberg A; Espes D; Carlsson PO; Ludvigsson J
    BMJ Open Diabetes Res Care; 2022 Nov; 10(6):. PubMed ID: 36384886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of adiponectin and leptin with autoimmunity in children with new-onset type 1 diabetes: a pilot study.
    Hecht Baldauff N; Tfayli H; Dong W; Arena VC; Gurtunca N; Pietropaolo M; Becker DJ; Libman IM
    Pediatr Diabetes; 2016 Jun; 17(4):249-56. PubMed ID: 25754190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.